CoreFX Expands CoreNhanced Platform with eXoFunction and BioTransport to Enhance Stability, Taste, and Release in Nutraceuticals

CoreFX Ingredients LLC is further developing formulation science with the expansion of its CoreNhanced technology platform, introducing a dual-path approach designed to improve nutraceutical product performance from manufacturing through to in-body delivery. Announced ahead of Vitafoods Europe 2026, the company’s newly trademarked eXoFunction BioTransport technologies reflect a growing industry emphasis on not just ingredient selection, but how those ingredients behave across the full product lifecycle.¹ The company will be present at Stand 3F225 during Vitafoods to showcase CoreNhanced products including berberine, creatine, vitamin C, and CoQ10.

Functions of the New Technologies

As formulation complexity increases, particularly in high-load, multi-active systems, brands are under pressure to deliver products that balance efficacy with sensory appeal and manufacturability, the company explains. CoreFX’s platform responds to this need by integrating two complementary technological pathways. eXoFunction addresses challenges that occur outside the body, including stability, dispersibility, powder flowability, and taste masking in the finished products. These attributes are critical for actives such as creatine, berberine, vitamin C, and CoQ10, where poor solubility or bitterness can negatively impact both production efficiency and consumer experience.

BioTransport, designed to pick up where eXoFunction leaves off, is designed to optimize what happens after product ingestion. Drawing on pharmaceutical-inspired delivery concepts, the technology enables controlled, targeted, and timed nutrient release. This includes protecting sensitive actives through digestion and delivering them at specific sites within the body, whether through immediate, sustained, or delayed release profiles. Together, these technologies create a more holistic system that connects formulation performance with bioefficacy.

According to CEO Denis Neville, the company’s approach recognizes that product performance extends beyond the ingredient label. “Brands perform across a full format journey, not just what is in the bottle, and format performance extends beyond the nutrient or bioactive itself,”stated Neville, in the company announcement.“The CoreNhanced platform bridges in-product functionality and in-body bioefficacy to ensure brands improve consumer experience.”

The Need for Innovation in Nutrient Delivery

This dual-path strategy aligns with broader trends in product delivery technologies, which are increasingly being leveraged to address persistent formulation challenges—particularly for ingredients with known limitations in solubility or sensory characteristics. CoreNhanced technologies had been showcased earlier this year at Natural Products Expo West, with CoreFX emphasizing the importance of delivery systems in improving stability, taste, and bioavailability across diverse formats.² “Format innovation is accelerating across our industry, and it is exciting to help brands deliver high-dose, multi-functional, consumer-friendly,” Neville had stated in a press release. The platform is enhancing both physical performance and biological delivery, aiming to help brands differentiate themselves and meet the shifting needs of consumers.

CoreFX’s recent innovations underscore this positioning. The company has also recently expanded its CoreNhanced offerings to include vitamin C and CoQ10 systems, targeting sensitive actives that are prone to degradation or poor absorption. In addition to CoreNhanced, CoreFX is also highlighting advancements within its OmegaFX portfolio, including non-seed oil systems as well as an Ahiflower greens prototype designed for powder and beverage applications. These innovations highlight versatile, plant-based delivery formats.

The company aims to create custom solutions to meet the needs of customers and consumers, as part of its broader vision to use its technologies alongside its sustainability practices to offer health and wellness solutions. As the nutraceutical industry continues to evolve, platforms like CoreNhanced illustrate a shift toward integrated formulation solutions that address multiple performance variables simultaneously.

This article was created with assistance from AI. The content has been reviewed and edited by Erin McEvoy, Associate Editor. For more information on the extent and nature of AI usage, please contact us.

References

1. CoreFX. CoreFX Spotlights Dual-Path Platform Advances for Product Performance with New Patent Activity and Application-Ready Prototypes at Vitafoods Europe. April 16, 2026. Accessed April 22, 2026. Press release provided via email.
2. McEvoy E. CoreFX expands CoreNhanced technology targeting stability, taste, and bioavailability across formats. February 9, 2026. Accessed April 22, 2026. https://www.nutritionaloutlook.com/view/corefx-expands-corenhanced-technology-targeting-stability-taste-and-bioavailability-across-formats